ID29523A - Penggunaan benzoilgunidin-benzoilguanidin untuk pengobatan diabetes melitus yang tidak bergantung pada insulin - Google Patents

Penggunaan benzoilgunidin-benzoilguanidin untuk pengobatan diabetes melitus yang tidak bergantung pada insulin

Info

Publication number
ID29523A
ID29523A IDW00200101318A ID20011318A ID29523A ID 29523 A ID29523 A ID 29523A ID W00200101318 A IDW00200101318 A ID W00200101318A ID 20011318 A ID20011318 A ID 20011318A ID 29523 A ID29523 A ID 29523A
Authority
ID
Indonesia
Prior art keywords
benzoilgunidin
benzoilguanidin
insulin
rely
treatment
Prior art date
Application number
IDW00200101318A
Other languages
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus Minck
Didier Mesangeau
Liliane Doare
Micheline Kergoat
Original Assignee
Marck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marck Patent Gmbh filed Critical Marck Patent Gmbh
Publication of ID29523A publication Critical patent/ID29523A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
IDW00200101318A 1998-11-26 1999-11-16 Penggunaan benzoilgunidin-benzoilguanidin untuk pengobatan diabetes melitus yang tidak bergantung pada insulin ID29523A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122419 1998-11-26

Publications (1)

Publication Number Publication Date
ID29523A true ID29523A (id) 2001-09-06

Family

ID=8233036

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101318A ID29523A (id) 1998-11-26 1999-11-16 Penggunaan benzoilgunidin-benzoilguanidin untuk pengobatan diabetes melitus yang tidak bergantung pada insulin

Country Status (14)

Country Link
EP (1) EP1131064A2 (id)
JP (1) JP2002530325A (id)
KR (1) KR20010080597A (id)
CN (1) CN1328452A (id)
AR (1) AR023064A1 (id)
AU (1) AU1553500A (id)
BR (1) BR9915667A (id)
CA (1) CA2352154A1 (id)
CZ (1) CZ20011785A3 (id)
HU (1) HUP0104418A2 (id)
ID (1) ID29523A (id)
NO (1) NO20012563D0 (id)
PL (1) PL348152A1 (id)
WO (1) WO2000030624A2 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008769B1 (ru) * 2002-06-05 2007-08-31 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения диабета
US7381841B2 (en) 2003-08-22 2008-06-03 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE102004054847A1 (de) 2004-11-13 2006-05-24 Sanofi-Aventis Deutschland Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4437874A1 (de) * 1994-10-22 1996-04-25 Merck Patent Gmbh Alkyl-5-methylsulfonyl-benzoylguanidin-Derivate
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
WO2000030624A3 (en) 2000-10-05
BR9915667A (pt) 2001-08-14
CZ20011785A3 (cs) 2001-10-17
AU1553500A (en) 2000-06-13
KR20010080597A (ko) 2001-08-22
HUP0104418A2 (hu) 2002-04-29
AR023064A1 (es) 2002-09-04
NO20012563L (no) 2001-05-25
PL348152A1 (en) 2002-05-06
WO2000030624A2 (en) 2000-06-02
JP2002530325A (ja) 2002-09-17
NO20012563D0 (no) 2001-05-25
CA2352154A1 (en) 2000-06-02
EP1131064A2 (en) 2001-09-12
CN1328452A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
DK1223927T3 (da) Anvendelse af retigabin til behandling af neuropatiske smerter
ID26788A (id) Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin
IT1298413B1 (it) Dispositivo minifissatore esterno per il trattamento di ossa piccole
DE59913141D1 (de) Blutbehandlungsgerät
PL337362A1 (en) Treatment of diabetes by means of thiazolydinone and metformin
IL218909A0 (en) Treatment of diabetes
HUP0102074A3 (en) A medical apparatus for use by a patient for medical self treatment of diabetes
DE69936767D1 (de) Patientenmonitor
DK5098A (da) Endoskopisk behandlingsinstrument
EP1115422A4 (en) USE OF NON-PEPTIDYLIC COMPOUNDS FOR THE TREATMENT OF INSULIN-RELATED CONDITIONS
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
DK0861081T3 (da) Anvendelse af epinastin til behandling af smerter
GB9913322D0 (en) Medical calculator
NO992667L (no) Ny human <beta>2-integrin-<alfa>-subenhet
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU5840200A (en) Treatment of diabetes and related pathologies
DE59711597D1 (de) Implantierbares medizinisches Mehrfunktionsgerät
DK199800837A (da) Anlæg til behandling af emner
ID23692A (id) Penggunaan sebuah penghambat h<+>, k<+>-atpase pada perawatan polip-polip nasal
ID29523A (id) Penggunaan benzoilgunidin-benzoilguanidin untuk pengobatan diabetes melitus yang tidak bergantung pada insulin
DK0998291T4 (da) Behandling af diabetes med thiazolidindion og sulphonylurinstof
EP1435962A4 (en) TREATMENT OF DIABETES TYPE I